Has Curtis Mitchell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $18,696 in general payments to Curtis Mitchell, MD across 340 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Curtis Mitchell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Curtis Mitchell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Curtis Mitchell, MD

Vascular & Interventional Radiology · Fort Worth, TXNPI 1336262153

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 33.1% of the total. Reporting peaked in 2023 at $4,677 and has fallen 51.3% since, to $2,279 in 2025.

$18,696in general payments, 2019–2025

Across 340 payments — averaging $54.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bard Peripheral Vascular, Inc.$6K
Abbott$4K
Penumbra, Inc.$3K
Stryker$1K
Endologix LLC$762
W. L. Gore & Associates, Inc.$555
plus $3K from 20 others

What the payments were for

Consulting fees$2,13811%
Speaking & faculty fees$1,4408%
Travel & lodging$4,80426%
Food & beverage$10,24855%
Education$660%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bard Peripheral Vascular, Inc.	55	$6,192
Abbott	16	$3,629
Penumbra, Inc.	106	$3,268
Stryker	19	$1,260
Endologix LLC	4	$762
W. L. Gore & Associates, Inc.	12	$555
Balt USA, LLC	28	$475
Boston Scientific	19	$467
Medtronic(3 entities)	18	$347
Terumo Medical Corporation	4	$249
Shockwave Medical, Inc	14	$227
Angiodynamics, Inc.	5	$211
Sirtex Medical Inc	10	$173
Relievant Medsystems, Inc.	1	$150
Imperative Care, Inc	8	$147
Cardiva Medical, Inc.	4	$128
Cook Medical LLC	5	$88
BD	2	$72
Silk Road Medical, Inc.	1	$71
Microvention, Inc.	1	$59
Cardiovascular Systems Inc.	2	$55
Mozarc Medical US LLC	2	$37
Canon Medical Systems USA, Inc.	1	$22
Trisalus Life Sciences, Inc.	1	$20
Venturemed Group, Inc.	1	$18
Surmodics, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ABSOLUTE PRO$2,375
Indigo System$1,302
WAVELINQ$1,150
SUPERA$950
IVS - VERTEBRAL AUGMENTATION PRODUCTS$739
Torus Stent Graft System$619
ENDOCROSS Device$619
Intracept$600
Pristine$331
Indigo$232
Navicross$174
GlideWire$174
Azur CX Detachable$174
Lutonix Drug Coated Balloon$157
OPTABLATE$148
GORE VIABAHN Endoprosthesis$134
EXCLUDER AAA Endoprosthesis$121
GORE VIABAHN Endoprosthesis with Heparin$120
SPINEJACK$118
JETi Peripheral Catheter$118

How this compares

$18,696 in reported general payments places this provider in the 80th percentile of 299 vascular & interventional radiology providers in Texas.

See all vascular & interventional radiology providers in Texas →

Medicare billing

Part B allowed, 2024

$119,088

Medicare patients

2,003

Services billed

3,255

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	13	$48

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Fort Worth

Brice AndringFort Worth$63K
Rakesh AhujaFort Worth$24K
Orlando DiazHouston$611K
Rahul ShethHouston$410K
Miguel MonteroHouston$386K
Joshua KubanHouston$301K
Peiman HabibollahiHouston$254K
Ahmed Abdel AalHouston$147K
Varshana GurusamyHouston$141K
Sanjeeva KalvaDallas$128K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →